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Diffusion-Limited Interaction between Unfolded Polypeptides and the Escherichia 
coli Chaperone SecBt 
Peter Fekkes, Tanneke den Blaauwen, and Amold J. M. Driessen” 
Department of Microbiology and Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, 
Kerklaan 30, 9751 NN Haren, The Netherlands 
Received March I ,  1995; Revised Manuscript Received May 4, 1995@ 
ABSTRACT: SecB is a chaperone dedicated to protein translocation in Escherichia coli. SecB binds to a 
subset of precursor proteins, and targets them in a translocation-competent state to the SecA subunit of 
the translocase. The nature and kinetics of the interaction of SecB with polypeptides were studied by 
spectroscopic techniques using the reduced form of bovine pancreatic trypsin inhibitor (BPTI) as a model 
substrate. Binding of SecB to BPTI resulted in an increase in the fluorescence of the surface-exposed 
tryptophan residue 36 of SecB. SecB reversibly binds BPTI in stoichiometric amounts. Labeling of 
BPTI with the fluorophore acrylodan allowed the analysis of the binding reaction at nanomolar 
concentrations. High-affinity binding (KD of 5.4 nM) of labeled BPTI to SecB resulted in a blue shift of 
the acrylodan emission maximum and an increase in the fluorescence quantum yield, suggesting that 
BPTI binds in an apolar environment. Stopped-flow acquisition of rate constants of complex formation 
between SecB and BPTI yielded a second-order binding rate constant of 5 x lo9 M-’ s-l, and a dissociation 
rate constant of 48 s-’. These data demonstrate that in vitro, the association of SecB with polypeptide 
substrates is limited by the rate of collision. In  vivo, SecB binding is selective, and predominantly occurs 
with nascent polypeptides. Since these chains are not expected to fold into stable structures, SecB 
association may be govemed by “more or less” specific interactions and be limited by the rate of chain 
elongation rather than the rate of folding. 
Molecular chaperones are proteins that bind other proteins 
to assist them in correct folding (Bochkareva et al., 1988), 
and complex formation (Ellis & Hemmingsen, 1989), to 
prevent aggregation (Hartl et al., 1994), and to target them 
to the appropriate compartment (Kumamoto, 1991). In 
Escherichia coli, some of the precursor proteins designated 
to become secreted across the inner membrane are stabilized 
in a translocation-competent state by the chaperone SecB. 
SecB is a homotetrameric protein (Watanabe & Blobel, 1989) 
that forms a stoichiometric complex with precursor proteins 
(Lecker et al., 1989). Unlike many other chaperones, it has 
never been shown that ATP influences the interaction 
between SecB and its substrates. In vitro, SecB is capable 
of binding to a variety of unfolded proteins, but not to native 
proteins (Hardy & Randall, 1991). In vivo, however, SecB 
is found in complex with only a subset of proteins, most of 
them precursors of outer membrane proteins (Kumamoto, 
1989; Kumamoto & FrancetiC, 1993). SecB seems to act 
early in the translocation pathway as it is able to bind the 
precursor protein as a nascent chain while it emerges from 
the ribosome (Kumamoto & FrancetiC, 1993). This concept 
is reinforced by the observation that SecB is also needed 
for cotranslational translocation (Kumamoto & Gannon, 
1988). SecB is the major chaperone in protein translocation 
since it is the only one that binds to SecA, the peripheral 
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ATPase subunit of the precursor protein translocase (Hartl 
et al., 1990; Hoffschulte et al., 1994). This interaction is 
enhanced in the presence of precursor proteins. At the 
membrane surface, SecB transfers the precursor protein to 
SecA, and translocation is initiated at the expense of ATP 
[for reviews, see Wickner et al. (1991) and Driessen (1994)l. 
Although SecB has an apparent preference for precursor 
proteins, the signal sequence itself is generally not involved 
in this interaction (Collier et al., 1988; Gannon et al., 1989; 
Randall et al., 1991). In some cases, however, it can bind 
to SecB; e.g., the signal sequence of the outer membrane 
protein LamB is part of the binding site for SecB (Altman 
et al., 1990). The signal sequence retards the folding of the 
mature domain (Park et al., 1988), and it is believed that 
this retardation of folding allows SecB to discriminate 
between precursor proteins and other proteins in the cell, as 
formulated in the “kinetic partitioning model” (Hardy & 
Randall, 1991). In this model, cytosolic proteins would 
escape the stable interaction with SecB by folding more 
rapidly than precursor proteins, and the final distribution of 
the precursor protein among different pathways in the cell 
is determined by partitioning that is dependent on the rate 
of folding or aggregation relative to the rate of binding to 
the chaperone (Randall & Hardy, 1995). 
In order to interact efficiently with its polypeptide 
substrates, SecB should be able to associate with precursor 
proteins at a rate that is faster than the folding rate. On the 
other hand, rates of association should be sufficiently slow 
to prevent stable interactions with cytosolic proteins. Al- 
though there have been speculations on the rate by which 
SecB associates with polypeptide substrates (Randall & 
Hardy, 1995), experimental kinetic data are lacking. There- 
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Kinetics of SecB-Polypeptide Interaction 
fore, we used bovine pancreatic trypsin inhibitor (BPTI)' 
labeled with an environmentally sensitive fluorophore, in 
conjunction with stopped-flow spectrofluorometry, to analyze 
the kinetics of polypeptide binding to SecB. Polypeptide 
binding to SecB appears to be much faster than polypeptide 
chain elongation and folding. The implications of the results 
on the function and specificity of SecB are discussed. 
EXPERIMENTAL PROCEDURES 
Materials. Acrylodan [6-acryloyl-2-(dimethylamino)- 
naphthalene) and DPX [p-xylylenebis(pyridinium bromide)] 
were purchased from Molecular Probes, Inc. (Eugene, OR). 
Bovine pancreatic trypsin inhibitor (BPTI, Pronase) and 
proteinase K were from Boehringer (Mannheim, Germany). 
Other chemicals were obtained from commercial sources. 
Inverted E. coli inner membrane vesicles were prepared from 
Escherichia coli D10 (Crooke et al., 1988). 35S-Labeled 
proOmpA was synthesized and immunopurified as described 
(Crooke & Wickner, 1987). SecA (Cabelli et al., 1988) and 
unlabeled proOmpA (Crooke et al., 1988) were purified as 
described. 
Strains and Plasmids. All strains used were E.  coli K12 
derivatives. Cloning experiments were performed in DH5a 
(Hanahan, 1983). Single-stranded DNA for site-directed 
mutagenesis was isolated from CJ236 (Kunkel et al., 1987), 
and for sequencing from JMlOl (Yanisch-Perron et al., 
1985). Overexpression of SecB proteins was done in BL21/ 
DE3 (Studier & Moffat, 1986). The plasmid pAK330 is 
described by Kumamoto and Nault (1989), and pBluescript 
was purchased from Stratagene (La Jolla, CA). 
Acrylodan Labeling of BPTI. A sample of 50 pdmL BPTI 
was denatured and reduced in 5.4 M GdnHCl, 100 pM DTT, 
and 50 mM Tris-HC1, pH 7.6, at room temperature for 30 
min. Acrylodan (20 mM in dimethylformamiae) was added 
to a final concentration of 200 pM, and the labeling reaction 
was allowed to proceed ovemight at 4 "C. The reaction was 
terminated by the addition of 10 mM DTT, and after 15 min, 
25 mM iodoacetamide was added to eliminate free thiol 
groups. The acrylodan-labeled reduced BPTI (AR-BPTI) 
was separated from excess reagents by gel filtration on a 
Sephadex G-10 M column (Pharmacia, Upsalla, Sweden). 
Fractions were analyzed by fluorescence spectroscopy, using 
an excitation wavelength of 391 nm. Free acrylodan 
possesses an emission maximum of 540 nm (Prendergast et 
al., 1983) that was shifted to 505 nm for the bound acrylodan. 
The amount of acrylodan per BPTI was estimated from the 
ratio of the protein absorbance at 280 nm ( E  = 7750 M-I 
cm-') to the acrylodan absorbance at 360 nm [ E  = 12 900 
M-' cm-I (Prendergast et al., 1983)l. 
Reduced BPTI (R-BPTI) was made by denaturing and 
reducing 390 pg/mL BPTI in 5.4 M GdnHCl, 10 mM DTT, 
and 50 mM Tris-HC1, pH 7.6. After 30 min, 25 mM 
iodoacetamide was added and the R-BPTI was separated 
from an excess of reagents by gel filtration on a Sephadex 
G- 10 M column. 
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The plasmid 
pAK330 (Kumamoto & Nault, 1989) was digested with 
BamHI and MscI, and the 580 bp fragment on which secB 
is located was ligated into pBluescriptI1 KSf digested with 
BamHI and EcoRV to yield plasmid pET204. Trp-36 of the 
secB gene in pET204 was replaced by phenylalanine or 
tyrosine via site-directed mutagenesis (Kunkel et al., 1987). 
The W36F (5'-GAAAGATTTCCAACCAGAAGTTAAGCT- 
TGA, changed nucleotides are indicated in boldface) and 
TGA-3') primers were used to produce the plasmids pET205 
and pET206, respectively. All mutations were confirmed 
by single-stranded DNA sequencing (Sanger et al., 1977). 
The plasmids pET204, pET205, and pET206 were digested 
with FspI and KpnI, and the secB-containing fragment was 
ligated into pBluescriptI1 KS- digested with SmaI and KpnI 
to obtain pET210, pET211, and pET212, respectively. In 
this way, the secB genes were cloned behind the T7 promoter. 
Overexpression was obtained in E.  coli BL21/DE3 after 
induction of the T7 RNA polymerase by adding 1 mM IPTG. 
Purification of wild-type, W36Y, and W36F SecB was 
performed as described by Weiss et al. (1988). At the 
DEAE-Sepharose chromatographic step, W36Y SecB was 
found to elute at a slightly higher ionic strength as compared 
to the wild-type or W36F SecB. SDS-PAGE (Laemmli, 
1970) and subsequential Coomassie Brilliant Blue staining 
were done to verify the purity of the isolated proteins. To 
determine the concentration of the SecB proteins, amino acid 
analysis was done by Eurosequence (Groningen, The Neth- 
erlands). 
Translocation Assay. In vitro translocation of 35S-labeled 
proOmpA (in 50 pL) was performed as described (Hart1 et 
al., 1990) with 0.5 pg of SecA, 2 mM ATP, 10 mM 
phosphocreatine, and 2.5 pg  of creatine kinase in buffer B 
[50 mM HEPES-KOH (pH 7.6), 30 mM KCl, 2 mM DTT, 
and 0.5 mg/mL bovine serum albumin]. When indicated, 
0.5 pg  of SecB was added. 35S-Labeled proOmpA was 
diluted 40-fold from a solution of 8 M urea and 50 mM Tris- 
HC1, pH 7.6. When indicated, the mixture was preincubated 
for 30 min at 37 OC, followed by the addition of urea-treated 
E. coli D10 inverted inner membrane vesicles at a final 
protein concentration of 44 pg/mL. Reactions were incu- 
bated for 30 min at 37 "C, and stopped by cooling on ice. 
Samples were treated with proteinase K (1 mg/mL) for 30 
min on ice, and terminated by the addition of PMSF (2 mM, 
final concentration). Samples were precipitated with 6.7% 
(w/v) trichloroacetic acid and analyzed by SDS-PAGE and 
autoradiography. 
Steady-State Fluorescence Measurements. All steady-state 
fluorescence measurements were performed at 25 "C using 
the SLM Aminco 4800C spectrofluorometer. Tyrosine and 
tryptophan emission spectra were recorded (scan rate of 1 
nrn/s) between 300 and 420 nm, using excitation wavelengths 
of 280 and 297 nm and a slitwidth of 2 nm. Acrylodan 
fluorescence was recorded between 400 and 600 nm, using 
an excitation wavelength of 391 nm and a slitwidth of 4 nm. 
Slow-time-based Trp fluorescence measurements were con- 
ducted at excitation and emission wavelengths of 300 nm 
(slitwidth of 2 nm) and 344 nm (slitwidth of 4 nm), 
respectively. For AR-BPTI, excitation and emission were 
at 391 nm ( f 4  nm) and 480 nm ( f 8  nm), respectively. AR- 
BPTI fluorescence was corrected for the time-dependent 
bleaching of the acrylodan group. 
Mutagenesis and Protein Purification. 
W36Y (5'-GAAAGATTACCAACCAGAAGTTAAGCT- 
I Abbreviations: acrylodan, 6-acryloyl-2-(dimethylamino)naphtha- 
lene; DPX, p-xylylenebis(pyridinium bromide); BFTI, bovine pancreatic 
trypsin inhibitor; R-BPTI, reduced BPTI; AR-BPTI, acrylodan-labeled 
reduced BPTI; GdnHC1, guanidinehydrochloride; DTT, dithiothreitol; 
IPTG, isopropyl l-thio-P-D-galactopyranoside; PMSF, phenylmethane- 
sulfonyl fluoride; kobs, pseudo-first-order rate constant; k,,,, second- 
order binding rate constant; &, first-order dissociation rate constant. 
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Quenching studies of the Trp fluorescence with the water- 
soluble quencher DPX were performed with excitation and 
emission wavelengths of 297 and 344 nm, respectively. 
Quenching constants were obtained by fitting the data to the 
Stern-Volmer equation: 
where Fo is the initial fluorescence, F the fluorescence in 
the presence of quencher, KQ the Stem-Volmer constant, 
and [Q] the concentration of the quencher. 
Stopped-Flow Fluoi.escence Measurements. Stopped-flow 
fluorescence measurements were performed on the SLM 
Aminco 4800C spectrofluorometer with the Milliflow stopped- 
flow reactor at a temperature of 25 "C. The estimated dead- 
time of the stopped-flow reactor is 10 ms. Excitation was 
at 380 nm using a slitwidth of 4 nm. Emission was measured 
with a high-pass filter with a cutoff of 400 nm. Data were 
fitted to the first-order reaction A-C or to the successive 
first-order reaction A-B-C, where A is the start situation, 
B an intermediate, and C the end product. The concentra- 
tions of A, B, and C will change in time according to 
[A], = Aoe-'I' 
(3) 
k ,  klebk2' 
[C], = A o  1 - 1 -I-  [ ( k2 - I,)""' + 
in which A0 is the concentration of A at t = 0, and [A],, 
[B],, and [C], are the concentrations of A, B, and C at time 
t ,  respectively. k l  is the reaction rate of the conversion of 
A to B, and k2 that of B to C. The total fluorescence will 
change in time according to 
where F ,  is the fluorescence at time t ,  andf,,fb, andf,. are 
the fluorescence factors for A, B, and C, respectively. 
RESULTS 
Tiy tophan Residue 36 of SecB Reports the Binding of 
Pi*ecur:c.oi- Proteins. The intrinsic tryptophan fluorescence 
of proteins has been used to obtain qualitative information 
on the folding state of a protein when it forms a complex 
with a molecular chaperone. Measurements of the interaction 
between SecB and precursor proteins that contain one or 
more Trp residues may be complicated by the presence of a 
single Trp residue at position 36 in SecB. Therefore, we 
replaced it for a tyrosine (W36Y SecB) or phenylalanine 
(W36F SecB). Mutant SecB proteins were overexpressed 
and purified from an E. coli strain expressing normal levels 
of wild-type SecB. Both mutants showed a greatly reduced 
Trp fluorescence (excitation at 280 nm, i.e., excitation of 
both Tyr and Trp; inset, Figure l), although some contami- 
nating Trp background fluorescence appeared to be present 
in W36F SecB (excitation at 297 nm, i.e., excitation of Trp 
alone; Figure 1). This contamination likely arises from 
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FIGURE 1 : Fluorescence spectra of the purified wild-type and mutant 
SecB proteins. Intrinsic tryptophan fluorescence spectra of wild- 
type (-), W36F (- -), and W36Y (.-*) SecB using an excitation 
wavelength of 297 nm. Solutions were prepared at a final 
concentration of 80 pg/mL protein. Inset: Fluorescence spectra of 
wild-type (-), W36F (- -), and W36Y ( - * * )  SecB recorded with 
an excitation wavelength of 280 nm. 
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FIGURE 2: SecB-dependency of the translocation of proOmpA into 
urea-treated inner membrane vesicles. Translocation reactions were 
assayed as described under Experimental Procedures with the 
following modifications or additions: lane 1, no SecA, SecB, or 
ATP added; lanes 2 and 5, no SecB added; lanes 3 and 6, wild- 
type SecB; and lanes 4 and 7, W36Y SecB. In lanes 1-4, the %- 
labeled proOmpA was immediately translocated after dilution from 
urea. In lanes 5-7, the proOmpA was first preincubated for 30 
min at 37 "C prior to the initiation of the translocation reaction. 
resolved from the wild-type SecB in the chromatographic 
steps (data not shown). Further experiments were, therefore, 
conducted with W36Y SecB. 
In order to determine if W36Y SecB has the same binding 
and targeting properties as SecB, the in vitro translocation 
of urea-denatured proOmpA, the precursor of the outer 
membrane protein OmpA, in the presence of SecB was 
examined. Translocation was more efficient in the presence 
of wild-type (Figure 2, lane 3) and W36Y (lane 4) SecB 
protein than in their absence (lane 2). Urea-denatured 
proOmpA becomes translocation-incompetent when it is first 
diluted into buffer and incubated for 30 min in the absence 
of SecB (lane 5 )  (Lecker et al., 1989). The addition of wild- 
type or W36Y SecB after this 30 min preincubation time 
had little effect on the translocation efficiency (data not 
shown). In contrast, when wild-type (lane 6) and W36Y 
(lane 7) SecB were present during the preincubation period, 
a significant portion of the proOmpA remained translocation- 
competent. Similar results were obtained with W36F SecB 
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FIGURE 3: Tryptophan fluorescence of SecB/proOmpA complexes. 
Fluorescence spectra of proOmpA in complex with wild-type SecB 
(-), proOmpA in complex with W36Y SecB (- -), and proOmpA 
in the absence of SecB e..). Spectra were recorded with an 
excitation wavelength of 297 nm, and corrected for background 
SecB fluorescence. The final proOmpA and SecB concentrations 
were 50 and 80 pg/mL, respectively. 
(data not shown). These data demonstrate that the W36Y 
and W36F SecB proteins have retained their activity. 
W36Y SecB allows the analysis of the binding to 
proOmpA in a spectroscopically clear background. Pro- 
OmpA is a 346 amino acid polypeptide with 5 tryptophanyl 
residues in the amino-terminal half (residues 30, 36,78, 123, 
and 164) (Chen et al., 1980). The fluorescence properties 
of these tryptophanyl residues respond to the folding state 
of proOmpA (Lecker et al., 1990). Little difference was 
notable between the fluorescence emission spectra of pro- 
OmpA free in solution or bound to W36Y SecB (Figure 3). 
In contrast, when proOmpA is in complex with the wild- 
type SecB, a higher Trp fluorescence is observed when the 
signal is corrected for the Trp fluorescence of native SecB 
(Figure 3). This must imply that the fluorescence intensity 
of Trp-36 is increased when SecB binds to proOmpA. 
SecB Forms a Stoichiometric Complex with the Model 
Protein R-BPTI. The quantum yield of the Trp fluorescence 
enhancement of SecB upon precursor protein binding is too 
small to detect binding events close to the expected KD, 
which is in the subnanomolar range. Moreover, the contri- 
bution of the five Trp residues of proOmpA to the fluores- 
cence signal interferes with a proper interpretation of the 
binding studies, while proOmpA aggregates when it is 
present in excess over SecB (Lecker et al., 1990; data not 
shown). Therefore, we used a model protein to study the 
kinetics of the interaction between SecB and polypeptide 
substrates. Bovine pancreatic trypsin inhibitor (BPTI) has 
proven to be a good substrate for SecB when it is present in 
its reduced form (Hardy & Randall, 1991). BPTI is a protein 
with a molecular mass of 6 kDa, and it is devoid of 
tryptophan residues. It contains three disulfide bonds that 
stabilize the tertiary structure. By blocking the reduced 
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FIGURE 4: Stoichiometry of the binding of reduced BPTI to SecB. 
The change in intrinsic Trp fluorescence of SecB (3.2 p M )  was 
recorded in the presence of increasing amounts of R-BPTI. Inset: 
Quenching of the tryptophan fluorescence of SecB by DPX. The 
tryptophan fluorescence of SecB at 344 nm was determined in the 
presence of increasing concentrations of DPX for wild-type SecB 
(H), SecB in complex with R-BPTI (0), and SecB denatured in 
5.4 M GdnHCl (A). 
conformation without any pronounced nativelike secondary 
structures (Gussakovsky & Haas, 1992). This state is further 
referred to as R-BPTI. The change in the intrinsic Trp 
fluorescence of SecB was used to determine the stoichiom- 
etry of R-BPTI binding. The Trp fluorescence of SecB 
increased with the amount of R-BPTI added, reaching a 
maximum value of 1.5 times that of unliganded SecB (Figure 
4). The Trp fluorescence level saturated at a concentration 
of R-BPTI that was approximately equal to that of the SecB 
monomer. These data suggest that R-BPTI binds in a 
stoichiometric fashion to the SecB monomers, which is in 
agreement with proteolysis studies (Randall, 1992). The 
increase in Trp fluorescence was accompanied by a small 
blue shift of the fluorescence emission maximum, i.e., from 
340 to 336 nm. This shift is indicative for a change in the 
polarity of the environment of Trp-36. The accessibility of 
Trp-36 for the hydrophilic quencher DPX was determined 
(inset, Figure 4), and it, as defined by the Stem-Volmer 
quenching constant, KQ, slightly increased when SecB was 
denatured in 5.6 M GdnHCl solution, i.e., KQ values of 29 
and 40 M-l, respectively. The value for KQ was not changed 
upon binding of R-BPTI to SecB. These results demonstrate 
that Trp-36 is exposed to an aqueous environment, and that 
the accessibility for DPX remains unchanged upon binding 
SecBIR-BPTI Complexes Are Readily Exchangeable. The 
exchange of R-BPTI between wild-type and W36Y SecB 
was followed by changes in the Trp fluorescence. First, an 
equimolar complex of wild-type SecB was formed with 
R-BPTI. Complex formation was evident from the increase 
in Trp fluorescence (Table 1). When the concentration of 
total SecB was enhanced by a factor of 2 by adding an 
equimolar amount of W36Y SecB, the change in Trp 
fluorescence dropped within the mixing time (1-2 s; see 
by R-BPTI. 
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Table 1: Relative Changes in the Tryptophan Fluorescence of SecB 
uuon Binding and Release of R-BPTI 
~ 
addition 
sample 1 2 A F 3 -  (A.U.)” 
wild-type SecB R-BPTI 0.49 i 0.06 
R-BPTI W36Y SecB 0.21 i 0.06 
W36Y SecB R-BPTI 0.04 i 0.03 
R-BPTI wild-type SecB 0.26 f 0.05 
a The change in tryptophan fluorescence of wild-type SecB (excita- 
tion at 297 nm, emission at 344 nm) was followed after subsequent 
additions of R-BPTI and W36Y SecB to wild-type SecB or, in the 
reversed case, to W36Y SecB. Values were corrected for the 
background fluorescence of unliganded wild-type SecB. A.U. = 
arbitrairy units. 
below) by approximately 50%. This implies that there is a 
rapid redistribution of the R-BPTI between wild-type and 
W36Y SecB. The reversed experiment, i.e., addition of SecB 
to a preformed complex of W36Y SecB and R-BPTI, is also 
shown in Table 1. In this case, the Trp fluorescence 
increased to the level observed for the reversed order of 
additions (Table 1) when corrected for the increase in Trp 
fluorescence due to the addition of SecB. These data 
demonstrate that the R-BPTI/SecB complex is readily 
dissociable and that the R-BPTI can be rapidly exchanged 
between SecB molecules. 
AR-BPTI Associates with a Hydrophobic Polypeptide 
Binding Pocket of SecB. From the increase in intrinsic Trp 
fluorescence of SecB upon peptide binding, an estimate has 
been made of the affinity of SecB for R-BPTI (Hardy & 
Randall, 1991). The quantum yield of the Trp fluorescence 
of SecB is, however, too low to perform binding experiments 
at concentrations near to the assumed KD of SecB for 
R-BPTI. Therefore, we used the environmentally sensitive 
fluorophore acrylodan to label R-BPTI. When excited at 
390 nm, acrylodan emits fluorescence between 450 and 520 
nm with a high quantum yield (Prendergast et al., 1983). 
Acrylodan-labeled reduced BPTI (AR-BPTI) binds to SecB 
with a concomitant increase in acrylodan fluorescence, and 
a shift in the emission maximum from 505 to 487 nm (Figure 
5). The blue shift and increase in fluorescence quantum yield 
are indicative for a transfer of the acrylodan to a more apolar 
environment upon binding to SecB (Prendergast et al., 1983). 
The change in fluorescence could be measured at very low 
concentrations of both AR-BPTI and SecB. A fixed 
concentration of AR-BPTI of 0.7 nM was used wherein SecB 
was titrated. The acrylodan fluorescence increased with the 
amount of SecB added, reaching a maximum value of 3.35 
times that of unliganded AR-BPTI (inset, Figure 6). Scat- 
chard analysis (Scatchard, 1949) revealed that the affinity 
of SecB for AR-BPTI is very high, Le., a KD of 5.4 nM (f0.6 
nM, n = 2 )  (Figure 6), and close to the value reported for 
R-BPTI (Hardy & Randall, 1991). These data also demon- 
strate that the binding of AR-BPTI to SecB is noncoopera- 
tive, Competition experiments between AR-BPTI and 
R-BPTI indicated that both substrates bind with similar 
affinity to SecB (data not shown). W36Y SecB binds AR- 
BPTI with a slightly increased affinity, Le., a KD of 3.1 nM 
( f0 .5  nM, n = 2) .  To ascertain that AR-BPTI and 
proOmpA bind to the same binding site on SecB , competition 
experiments were performed by titrating variable amounts 
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FIGURE 5: Acrylodan fluorescence emission spectra of AR-BPTI 
in the absence (a)  and presence of an excess of SecB (b). AR- 
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FIGURE 6: Scatchard plot analysis of the binding of AR-BPTI to 
wild-type (0) and W36Y (0) SecB. AR-BPTI was present at a 
concentration of 0.7 nM, and the SecB concentration was varied 
between 0 and 100 nM. Excitation and emission were at 391 and 
480 nm, respectively. Experiments were performed in duplo. 
Inset: Semilogarithmic representation of the binding of AR-BPTI 
to wild-type (0) and W36Y (0) SecB. 
BPTI complex. AR-BPTI bound to SecB was nearly 
completely displaced by a stoichiometric amount of pro- 
OmpA, Le., 1 mol of proOmpA per 4 mol of SecB monomers 
(data not shown), demonstrating that AR-BPTI and pro- 
OmpA compete for the same binding site on SecB. More- 
over, it implies that proOmpA binds with much higher 
affinity to SecB than AR-BPTI. Aggregation of proOmpA 
was observed when the protein was present in excess to 
SecB . 
Kinetics of SecB -Polypeptide Interaction 
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determined in a direct manner (Figure 7A), suggesting that 
the rate of AR-BPTI association to SecB is diffusion-limited. 
DISCUSSION 
For the first time, kinetic data on the interaction of the 
molecular chaperone SecB with a polypeptide substrate are 
presented. SecB is a chaperone dedicated to facilitate the 
export of precursor proteins in E. coli (Wickner et al., 1991). 
To determine the polypeptide binding kinetics, bovine 
pancreas trypsin inhibitor (BPTI) was used as a substrate as 
this protein remains soluble in its unfolded, reduced state. 
BPTI binds with high affinity to SecB, and this binding is 
competed by precursor proteins (Hardy & Randall, 1991; 
this paper). Although polypeptide binding to SecB can be 
detected as an increase in the intrinsic tryptophan fluores- 
cence of SecB, this method is not sensitive enough to 
measure the kinetics of binding. Therefore, BPTI was 
labeled with the environmentally sensitive fluorophore acry- 
lodan, which possesses a much higher quantum yield. Direct 
measurements demonstrate that the association rate constant 
(kass) for the interaction of SecB with acrylodan-labeled BPTI 
is on the order of 5 x lo9 M-' s-'. Determination of the 
dissociation rate constant and the KD provides an altemative 
means to estimate k,,,, producing a value of around 9 x lo9 
M-' s-l. The experimentally determined value for k,,, is in 
the range of the collisonal rate of molecules of this size (Janin 
& Chotia, 1990; Pontius, 1993), suggesting that the binding 
of SecB to polypeptide substrates is limited by diffusion. 
The extremely fast association kinetics have important 
consequences for the functioning of SecB in vivo. The 
kinetic partitioning model of selective binding of nonnative 
proteins by SecB predicts that the pathway a polypeptide 
takes in vivo depends on the rate of folding and/or aggrega- 
tion relative to the rate of its association with SecB (Hardy 
& Randall, 1991). Proteins that fold rapidly are precluded 
from binding, whereas the presence of a signal sequence 
which has been shown to retard folding of precursor proteins 
(Park et al., 1988; Laminet & Pluckthun, 1989) would favor 
association with SecB and direct the precursor protein into 
the pathway leading to export. This theory is partially based 
on the assumption that SecB interacts with precursor proteins 
with a k,,, of about lo8 M-' s-! (Randall et al., 1994). The 
k,,, value experimentally determined for unfolded BPTI is 
at least 10-fold higher. It is important to emphasize that 
due to technical limitation in the stopped-flow experiments 
the kobs represents a minimal value, and could well be greater. 
With an assumed free cellular SecB concentration of 0.4 p M  
(Hardy & Randall, 1991), the pseudo-first-order rate for 
association with SecB would be in the range of 400 s-l rather 
than the suggested 40 SKI. This is far in excess to estimates 
of the rate of cytosolic protein folding in vitro of 5-10 s-' 
(Hardy & Randall, 1991). In vivo, the rate of protein folding 
is likely to be limited by the rate of translation. Our data 
show that the interaction of SecB with an unfolded polypep- 
tide chain can occur on a millisecond time scale, while 
extrusion of a protein from the ribosome takes seconds to 
minutes (Freedman, 1992). It appears that SecB is optimized 
to collide nonspecifically with macromolecules at the highest 
possible rate (Pontius, 1993). In the cell, the size of SecB 
and the viscosity of the cytosol, densely packed with protein 
and other components, will govern the rate of association. 
KD values in vivo are, therefore, likely to be poorer than 
observed in vitro. 
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In vivo, SecB binding is highly selective (Kumamoto, 
1989). SecB appears to be mainly associated with nascent 
chains in the cell (Kumamoto & FrancetiC, 1993). Under 
the conditions tested, these were preLamB, preMBP (maltose 
binding protein), proOmpA, preOmpF, and an unidentified 
protein. Nascent polypeptides are not expected to adopt a 
stable structure; they also cannot retain an extended confor- 
mation. The consensus from refolding experiments is that 
early elements of folded structure, although they may be 
nativelike, are in rapid equilibrium with the unfolded state. 
The formation of a stable structure requires the presence of 
a complete protein domain. Before this has happened, 
binding of SecB has likely occurred. In addition, the 
bacterial homolog of signal recognition particle (SRP) 
associates with nascent chains at a very early state by binding 
to their signal sequence (Luirink et al., 1992). This may 
further prevent the stable folding of polypeptide domains 
bound to the ribosome. Therefore, we conclude that in vivo, 
the binding affinity for SecB is more likely to be decisive 
for a stable interaction rather than the rate of folding. Once 
a polypeptide has folded to its nativelike structure, the site 
that is recognized by SecB may be buried and thus inacces- 
sible for interaction. In this respect, the rate of unfolding 
and the lifetimes of folding intermediates may further 
facilitate this interaction in vitro. It is important to realize 
that SecB must be highly selective in vivo since cells are 
hardly hampered by the massive overproduction of SecB 
(Weiss et al., 1988). 
What elements of a nonnative protein determine this 
affinity, and why are these elements specific for precursor 
proteins? It has been proposed that SecB binds preferentially 
at sites exhibiting p-structure (MacIntyre et al., 1991; 
Breukink et al., 1992). Mapping of putative binding domains 
in precursor proteins either by genetic or by biochemical 
means has sofar not provided any insight in the rules that 
dictate specificity. It has also been suggested that precursor 
proteins harbor at the most two binding regions (Gannon et 
al., 1989; Altman et al., 1990; De Cock et al., 1992). In 
preMBP and preGBP (galactose binding protein), the binding 
region appears to be positioned in the middle of the primary 
sequence (Collier et al., 1988; Randall & Hardy, 1995). This 
must imply that SecB will bind these nascent chains with 
high affinity only when a major portion of the protein has 
emerged from the ribosome. In this context, SecB appears 
to bind only very large nascent chains (Kumamoto & 
FrancetiC, 1993), while SW associates with short polypeptide 
chains (Luirink et al., 1992). This means that SRP- and 
SecB-dependent pathways either coexist for general protein 
export or represent different stages in the precursor protein 
targeting cascade. 
SecB does not bind pre-P-lactamase, both in vivo and in 
vitro (Laminet et al., 1991). It has been suggested that the 
lack of interaction could be due to a rapid transition of 
unfolded pre-P-lactamase into an intermediate form that is 
not recognized by SecB (Zahn et al., 1994). Alternatively, 
it was proposed that pre-p-lactamase simply lacks a structural 
element that can be recognized by SecB. The latter seems 
more likely considering the extremely fast kinetics that allow 
SecB to bind to nonnative proteins. 
SecB senses polypeptide binding through a conformational 
change that results in an increase in the intrinsic tryptophan 
fluorescence (Randall & Hardy, 1991; this paper). The Trp 
fluorescence of nonliganded SecB is rather low, but increases 
Fekkes et al. 
50% upon polypeptide binding. In the case of the proOmpA/ 
SecB complex, a significant contribution of Trp-36 of SecB 
to the total fluorescence signal is evident (Figure 3). Our 
data suggest that Trp-36 of SecB is surface-exposed, both 
in the liganded and in the nonliganded state. The increase 
in Trp fluorescence is likely the result of a relieve of 
quenching. In the nonliganded form, Trp-36 may be 
quenched by ionized amino acid side chains located in the 
vicinity. Mutational analysis demonstrates that Trp-36 of 
SecB is not essential for binding. Although the intrinsic Trp 
fluorescence was insensitive as a probe of polypeptide 
binding in kinetic experiments, it allowed us to determine 
the number of BPTI molecules bound per SecB homotet- 
ramer. The SecB homotetramer binds four BPTI molecules, 
indicating that it harbors four polypeptide binding sites. 
Proteolysis studies have led to the same conclusion (Randall, 
1992). Both at high and at low SecB concentration, it 
appears that there is no cooperativity in the binding of BPTI 
between the monomers of the SecB homotetramer. In 
contrast to BPTI, which is a small protein, the large precursor 
proteins bind to the SecB homotetramer in stoichiometric 
amounts (Lecker et al., 1990). It may contact the SecB 
homotetramer at its four binding sites simultaneously, giving 
rise to very tight binding. 
Binding of AR-BPTI to SecB causes a shift in the emission 
maximum of the acrylodan fluorescence. This is indicative 
for a change from a polar to an apolar environment. It has 
been shown that SecB exposes a hydrophobic region upon 
the low-affinity binding of small peptides carrying a positive 
charge (Randall, 1992). This region becomes exposed only 
after occupation of all of the sites on SecB. In the case of 
AR-BPTI, that binds with high affinity, the increase in 
fluorescence is noncooperative. Binding of AR-BPTI always 
results in an increase in fluorescence. The lack of cooper- 
ativity suggests that this hydrophobic binding site on SecB 
might be different from the domain described by Randall 
(1992). Binding of a substrate to SecB must at least partially 
involve hydrophobic interaction. 
SecB targets precursor proteins to SecA, the peripheral 
ATP binding subunit of the translocase. It binds with high 
affinity to SecA both in solution and at the membrane surface 
(Hart1 et al., 1990; Hoffschulte et al., 1994). This interaction 
is stimulated by precursor proteins. PrlAIPrlG mutants of 
E. coli suppress certain signal sequence defects, and even 
allow the translocation of signal sequence-less proteins 
(Derman et al., 1993; Flower et al., 1994). These proteins 
are translocated in a SecB-dependent manner only, even 
though they are translocated SecB-independently as a full- 
size precursor protein. This suggests that the targeting 
function of SecB can compensate for the lack of a signal 
sequence, and gives strong support to the view that SecB 
functions as a coupling factor to allow efficient targeting 
and transfer of precursor proteins from the ribosome to the 
translocase (Kumamoto & FrancetiC, 1993). Moreover, it 
indicates that SecB has the ability to interact with other 
proteins not belonging to the subset of SecB-requiring 
precursor proteins. 
A kinetic analysis of the interaction of an acrylodan- 
labeled peptide with the E .  coli DnaK revealed a k,,, of 9400 
M-' s-l (Schmid et al., 1994). This rate is lo5 times lower 
than the k,,, determined for the binding of SecB to AR-BPTI. 
DnaK transiently sequesters unfolded segments of proteins 
when they emerge from the ribosome and promote their 
Kinetics of SecB -Polypeptide Interaction 
correct folding (Hartl et al., 1994). The number of SecB 
(Watanabe & Blobel, 1989) and DnaK (Neidhard & Van 
Bogelen, 1987) molecules in growing cells is about 1200 
(tetramers) and 2500 (dimers), respectively. Since these 
values are in the same order, one would expect that 
polypeptides are first bound by SecB before DnaK can 
interact. Obviously, this view is too simple, and other factors 
such as specificity and/or co-chaperones have to be impli- 
cated. It will be important to mimic the in vivo conditions 
of polypeptide binding more closely, for instance, by defining 
the selectivity and timing of SecB binding to nascent chains 
in cell-free extracts. 
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